Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2026-09-10 09:21:32 ET · period of report 2026-09-09 · accession 0001214659-26-011541 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-10 09:21 | 2026-09-09 | AQST | Boyd Peter E. | CHRO | X - OptEx | $0.96 | +2,293 | 284.0K | +0.8% | +$2,201 |
| D | 2026-09-10 09:21 | 2026-09-09 | AQST | Boyd Peter E. | CHRO | X - OptEx | $0.00 | -2,293 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-09 | X | A | 2,293 | $0.96 | 284,024 | D | — | — | (F1) Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share. (F1) Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share. |
| 2 | Derivative | Warrant (Right to Buy) | 2026-09-09 | X | D | 2,293 | $0.00 | 0 | D | $0.96 · 2022-12-08 to 2027-06-08 | 2,293 Common Stock |